Compare ALXO & NLOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALXO | NLOP |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.9M | 176.7M |
| IPO Year | 2020 | 2022 |
| Metric | ALXO | NLOP |
|---|---|---|
| Price | $1.79 | $11.39 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $3.50 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 110.2K |
| Earning Date | 05-08-2026 | 05-19-2026 |
| Dividend Yield | N/A | ★ 52.20% |
| EPS Growth | ★ 26.36 | N/A |
| EPS | N/A | ★ 1.69 |
| Revenue | N/A | ★ $118,915,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.78 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.41 | $11.24 |
| 52 Week High | $2.66 | $34.53 |
| Indicator | ALXO | NLOP |
|---|---|---|
| Relative Strength Index (RSI) | 54.99 | 33.61 |
| Support Level | $1.54 | $11.34 |
| Resistance Level | $2.27 | $12.26 |
| Average True Range (ATR) | 0.12 | 0.29 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 97.62 | 15.04 |
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
Net Lease Office Properties is a Maryland real estate investment trust that, together with its consolidated subsidiaries, owns, operates, and finances a diversified portfolio of office properties mainly leased to corporate tenants on a single-tenant, net-lease basis. The company operates as a single operating and reportable segment focused on owning and managing office properties that generate revenue mainly from long-term lease agreements with tenants.